223 related articles for article (PubMed ID: 36895966)
1. N7-methylguanosine regulatory genes well represented by METTL1 define vastly different prognostic, immune and therapy landscapes in adrenocortical carcinoma.
Xu F; Cai D; Liu S; He K; Chen J; Qu L; Chong T; Li X; Ren B
Am J Cancer Res; 2023; 13(2):538-568. PubMed ID: 36895966
[TBL] [Abstract][Full Text] [Related]
2. N7-Methylguanosine Regulatory Genes Profoundly Affect the Prognosis, Progression, and Antitumor Immune Response of Hepatocellular Carcinoma.
Zhou K; Yang J; Li X; Xiong W; Zhang P; Zhang X
Front Surg; 2022; 9():893977. PubMed ID: 35784919
[TBL] [Abstract][Full Text] [Related]
3. M7G methylated core genes (METTL1 and WDR4) and associated RNA risk signatures are associated with prognosis and immune escape in HCC.
Li R; Liu X; Deng K; Wang X
BMC Med Genomics; 2023 Aug; 16(1):179. PubMed ID: 37528384
[TBL] [Abstract][Full Text] [Related]
4. Integrative pan-cancer analysis and clinical characterization of the N7-methylguanosine (m7G) RNA modification regulators in human cancers.
He CM; Zhang XD; Zhu SX; Zheng JJ; Wang YM; Wang Q; Yin H; Fu YJ; Xue S; Tang J; Zhao XJ
Front Genet; 2022; 13():998147. PubMed ID: 36226166
[No Abstract] [Full Text] [Related]
5. Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer.
Li T; Chen Z; Wang Z; Lu J; Chen D
Front Immunol; 2023; 14():1260195. PubMed ID: 37868988
[TBL] [Abstract][Full Text] [Related]
6. WDR4 promotes HCC pathogenesis through N
Dong R; Wang C; Tang B; Cheng Y; Peng X; Yang X; Ni B; Li J
Cell Signal; 2024 Jun; 118():111145. PubMed ID: 38493882
[TBL] [Abstract][Full Text] [Related]
7. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
Ren L; Yang X; Liu J; Wang W; Liu Z; Lin Q; Huang B; Pan J; Mao X
Cancer Cell Int; 2023 May; 23(1):85. PubMed ID: 37158958
[TBL] [Abstract][Full Text] [Related]
8. N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma.
Maimaiti A; Feng Z; Liu Y; Turhon M; Xie Z; Baihetiyaer Y; Wang X; Kasimu M; Jiang L; Wang Y; Wang Z; Pei Y
Eur J Med Res; 2023 Mar; 28(1):144. PubMed ID: 36998056
[TBL] [Abstract][Full Text] [Related]
9. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
Cao J; Liang Y; Gu JJ; Huang Y; Wang B
Front Genet; 2022; 13():991162. PubMed ID: 36353118
[No Abstract] [Full Text] [Related]
10. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
[TBL] [Abstract][Full Text] [Related]
11. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival.
Liu P; Dong C; Shi H; Yan Z; Zhang J; Liu J
J Gastrointest Oncol; 2022 Dec; 13(6):3169-3182. PubMed ID: 36636051
[TBL] [Abstract][Full Text] [Related]
12. A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma.
Duan HP; Yan JH; Nie L; Wang Y; Xie H
BMC Pulm Med; 2023 Jan; 23(1):14. PubMed ID: 36635678
[TBL] [Abstract][Full Text] [Related]
13. m7G Methyltransferase METTL1 Promotes Post-ischemic Angiogenesis via Promoting VEGFA mRNA Translation.
Zhao Y; Kong L; Pei Z; Li F; Li C; Sun X; Shi B; Ge J
Front Cell Dev Biol; 2021; 9():642080. PubMed ID: 34136476
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of a novel cuproptosis signature for stratifying different prognostic, immune, metabolic, and therapeutic landscapes in pancreatic adenocarcinoma.
Yan X; Zheng W; Xu FS; Chang HL; Zhang Y; Zhang ZY; Zhang YH
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):2024-2050. PubMed ID: 38497885
[TBL] [Abstract][Full Text] [Related]
15. Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma.
Ke C; Dai S; Xu F; Yuan J; Fan S; Chen Y; Yang L; Li Y
BMC Cancer; 2023 Jan; 23(1):25. PubMed ID: 36611155
[TBL] [Abstract][Full Text] [Related]
16. Aberrant translation regulated by METTL1/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression.
Chen J; Li K; Chen J; Wang X; Ling R; Cheng M; Chen Z; Chen F; He Q; Li S; Zhang C; Jiang Y; Chen Q; Wang A; Chen D
Cancer Commun (Lond); 2022 Mar; 42(3):223-244. PubMed ID: 35179319
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma.
Wei W; Liu C; Wang M; Jiang W; Wang C; Zhang S
Front Genet; 2022; 13():906496. PubMed ID: 35938009
[TBL] [Abstract][Full Text] [Related]
18. A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma.
Yang S; Zhou J; Chen Z; Sun Q; Zhang D; Feng Y; Wang X; Sun Y
Front Oncol; 2022; 12():934928. PubMed ID: 35992788
[TBL] [Abstract][Full Text] [Related]
19. Identification of N
Ma X; Yang B; Yang Y; Wu G; Ma X; Yu X; Li Y; Wang Y; Guo Q
Front Genet; 2022; 13():946845. PubMed ID: 36105111
[TBL] [Abstract][Full Text] [Related]
20. P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC.
Zhang M; Kan D; Zhang B; Chen X; Wang C; Chen S; Gao W; Yang Z; Li Y; Chen Y; Zhu S; Wen S; Niu Y; Shang Z
J Exp Clin Cancer Res; 2023 Aug; 42(1):215. PubMed ID: 37599359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]